As governments and health authorities rush to meet the moment of a worsening Ebola outbreak in central Africa, Merck & Co. is considering dusting off its antiviral molnupiravir, which saw use as a ...
CHICAGO, June 1 (Reuters) - Merck (MRK.N), opens new tab is in discussions with various global health authorities about making its COVID antiviral pill molnupiravir available as an Ebola treatment to ...
Eli Lilly’s deals add late- and early-stage vaccine assets: a potentially better-tolerated shingles candidate, bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results